ARIAD to Present at the Cowen and Company 33rd Annual Health Care Conference
Cowen Group Healthcare Conference 2013
CAMBRIDGE, Mass. -- February 28, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the Cowen and Company 33^rd Annual Health Care Conference being
held in Boston. Harvey J. Berger, M.D., chairman and chief executive officer,
will provide an overview of the Company’s business on Wednesday, March 6, at
8:40 a.m. (ET).
The ARIAD presentation will be webcast live and can be accessed by visiting
the investor relations section of the Company's website at
http://www.ariad.com/investor. A replay of the presentation will also be
available and archived on the site for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and
Lausanne, Switzerland, is an integrated global oncology company focused on
transforming the lives of cancer patients with breakthrough medicines. ARIAD
is working on new medicines to advance the treatment of various forms of
chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer medicines.
For additional information, visit http://www.ariad.com or follow ARIAD on
ARIAD Pharmaceuticals, Inc.
Kendra Adams, 617-503-7028
Liza Heapes, 617-621-2315
Press spacebar to pause and continue. Press esc to stop.